Crossmark

Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters

Crossref DOI link: https://doi.org/10.1038/s41541-021-00321-8

Published Online: 2021-03-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jia, Qingmei https://orcid.org/0000-0002-2328-4806
Bielefeldt-Ohmann, Helle https://orcid.org/0000-0002-5332-5445
Maison, Rachel M. https://orcid.org/0000-0002-4003-2643
Masleša-Galić, Saša https://orcid.org/0000-0002-8200-6670
Cooper, Sarah K. https://orcid.org/0000-0001-9656-2283
Bowen, Richard A.

Horwitz, Marcus A. https://orcid.org/0000-0001-6525-7147
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | National Institutes of Health (AI141390)

UCLA AIDS Institute and Charity Treks
License Information

Text and Data Mining valid from 2021-03-30

Version of Record valid from 2021-03-30
More Information

Article History

Received: 22 December 2020

Accepted: 12 March 2021

First Online: 30 March 2021

Competing interests

: The authors declare no competing interests except M.A.H. and Q.J. are inventors on patent applications filed by UCLA that include data presented herein.

Document is current

Any future updates will be listed below